Start a new search
Other sectors:
About Kellysearch
- Home >
- Medical & Scientific >
- Sepracor Inc.
Sepracor Inc. in Marlborough, MA, US (United States)
Company Overview:
Crude or Botanical or Medicinal Drugs, Pharmaceutical Product Protection Systems, Central Nervous System Pharmaceuticals, Hypertension Treatment Pharmaceuticals, Respiratory Pharmaceuticals available from Sepracor Inc. based in Marlborough, MA. Click the links below to visit our website or contact us via our profile page.
Company Statistics:
ViewContact Details
Address:84 Waterford Drive, Marlborough, MA, 01752, United States
Telephone:+508 481 6700
Fax:
Sponsored Links
Nervous System Remedy
Homeopathic Supplement to Heal & Repair Damaged Nerves. All Natural!
News:
FDA Extends Sepracor, Inc. PDUFA Action Date for STEDESA; New Drug Application to Apri...
News
|
...As Email Print FDA Extends Sepracor, Inc. (SEPR) PDUFA Action Date...Mass.--(BUSINESS WIRE)--Sepracor Inc. today announced...epilepsy. About Sepracor Sepracor Inc., an indirect...
Chronic Obstructive Pulmonary Disease: Research on chronic obstructive pulmonary disea...
News
|
...disease detailed by scientists at Sepracor, Inc. Today's Medical & Research...Research on detailed by scientists at Sepracor, Inc. January 12th, 2010...disease detailed by scientists at Sepracor, Inc. More news items from: ...
FDA Extends PDUFA Action Date for Stedesa NDA - Zibb.com
News
|
FDA Extends PDUFA Action Date for Stedesa NDA Sepracor Inc. said that it has received notification from the U...partial-onset seizures in adults with epilepsy. Sepracor Inc., an indirect subsidiary of Dainippon Sumitomo Pharma...
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing wit...
News
|
...Laboratories, Inc. and most recently, as a Vice President at Sepracor Inc., where he worked from 1997 to 2007. During his tenure...technology working most recently at ABC Laboratories and Sepracor Inc. “We believe that AEROSPAN is an exciting opportunity...
Speculative Observation: Cephalon at $62.42 (at Seeking Alpha)
News
|
...pain, and oncology therapeutic areas. It competes against GlaxoSmithKline plc (GSK), Johnson & Johnson (JNJ), and Sepracor Inc. Because the company doesn't pay a dividend, the New Low Observer team has to classify such a security as a speculation...
Press Releases:
Chronic Obstructive Pulmonary Disease (COPD) - Drug Pipeline Analysis and Market Forec...
Press Release
|
...GlaxoSmithKline, Novartis AG, Pfizer Inc, AstraZeneca, Forest Laboratories, Merck & Co, Boehringer Ingelheim and Sepracor, Inc have some of the most technologically advanced products in their pipeline portfolios, and are therefore expected to...
Winston & Strawn Adds Team of Restructuring Attorneys and M&A Veteran to New York Offi...
Press Release
|
...industries. Last year he represented Stiefel Laboratories, Inc. in its $3.6 billion sale to GlaxoSmithKline plc. and Sepracor, Inc. in its $2.6 billion sale to a Japanese pharmaceutical company. He also has extensive experience in corporate...
FDA Extends PDUFA Action Date for STEDESA(TM) New Drug Application - Zibb.com
Press Release
|
...TM) New Drug Application Sepracor Inc. today announced that it has received...epilepsy. About Sepracor Sepracor Inc., an indirect, wholly owned...BROVANA are registered trademarks of Sepracor Inc. STEDESA is a trademark of BIAL...
Dainippon Sumitomo Pharma America Announces the NDA Submission of Lurasidone to the FD...
Press Release
|
...development presence in the areas of CNS, diabetes, cardiovascular disease, and inflammation/allergy. In October 2009, Sepracor Inc., based in Marlborough, MA, became a subsidiary of DSP. www.dsp-america.com SOURCE Dainippon Sumitomo...
Reportlinker Adds Epilepsy - Drug Pipeline Analysis and Market Forecasts to 2015
Press Release
|
... 7.5.3.1 Lyrica 7.6 Sepracor Inc 7.6.1 Overview 7.6...Pipeline Products, 2009 Table 16: Sepracor Inc. - CNS Marketed Products, 2009 Table 17: Sepracor Inc. - CNS Pipeline Products, 2009...
Web Pages:
Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal(R) So...
Web
|
...S. Food & Drug Administration and notified UCB Inc., the New Drug Application holder for Xyzal(R) solution and Sepracor Inc., the listed patent owner, of its filing. On June 17, 2009, Sepracor and UCB filed suit alleging patent infringement...
09-457 Sepracor Inc. ("SEPR/ERQ"): Merger Completed -- Cash Settlement
Web
|
...Members FROM: Scott Speer RE: Sepracor Inc. ("SEPR/ERQ"): Merger Completed...Merger has been completed between Sepracor Inc. ("SEPR/ERQ") and Aptiom...SEPR share. Please be aware that Sepracor Inc. had been the subject of a tender...
Sepracor Inc Company Details
Web
|
Sepracor Inc Suppliers Total : 1 View more » Sepracor Inc. Marlborough, MA (Massachusetts) US Crude or Botanical or Medicinal Drugs, Pharmaceutical Product Protection Systems, Central Nervous System Pharmaceuticals, Hypertension...
Rodman & Renshaw Annual Global Investment Conference
Video
|
...45 PM NewLink Genetics Corporation Hythiam, Inc. (NASDAQ: HYTM) MediGene AG (Frankfurt: MDG GR) Sepracor, Inc. (NASDAQ: SEPR) PolyMedix, Inc. (OTC BB: PYMX) BioSphere Medical, Inc. (NASDAQ: BSMD) Stroud...
Crystallization Scale-up Investigations using the RC1 with VisiMix and JMP - Sepracor ...
Web
|
...using the RC1 with VisiMix and JMP - Sepracor Inc. Crystallization Scale-up...the RC1 with VisiMix and JMP - Sepracor Inc. Andrei A. Zlota, Roger...Kostas Saranteas and Steve Wald, Sepracor Inc., USA. The RC1 was used...
